Kathy Ogilvie

Executive Vice President @Ventyx Biosciences

San Diego, CA, US
EMAILS
k•••••••@ventyxbio.com
MOBILE NUMBERS
+18•••••••93

Signup · Get unlimited contacts

WORK HISTORY

Jan 2026 — Present

Executive Vice President @Ventyx Biosciences

View department →

San Diego, US

EDUCATION

N/A

University of Delaware

Ph.D., Biological Sciences

N/A

Salk Institute for Biological Studies

Postdoctoral Research Associate, Biological Sciences

N/A

Indiana University of Pennsylvania

BS, Biology

SKILLS

MetabolismLifesciencesInflammationOncologyIn VitroIn VivoBiotechnologyPharmacologyDrug DiscoveryPharmaceutical IndustryDiabetesCell BiologyAnimal ModelsMetabolic SyndromeBiomarkers

ABOUT KATHY OGILVIE

I am a productive scientific leader trained in integrated physiology and endocrinology experienced in reproductive, neuroendocrine, inflammatory, and metabolic systems with over 20 years of industry experience managing in vivo pharmacology, interdisciplinary project and non-clinical development teams from target identification to the clinic. I have broad experience across the pharmaceutical and biotechnology industries and have successfully advanced small molecule, peptide, protein and antibody-based drug discovery projects. My responsibilities have spanned exploratory biology, pre-clinical pharmacology, non-clinical development and regulatory interactions. I have reduced experimental cycle times, improved data quality and increased efficiency in the the teams that I have managed. I have led efforts to select and validate targets and managed or made major contributions to 10 clinical candidates. In addition to a high level of organization, I have strong management/interpersonal skills, including mentoring scientists to promotions and graduate school. Lastly, I have a record of continuing public scientific engagement (e.g, publications and conference presentations) throughout my career.Specialties: In vivo pharmacology including models of metabolic disease, diabetes, obesity, cardiovascular disease, endocrinology, neuroendocrinology, reproduction, inflammation, immunity, and oncology. Non-clinical development including pharmacology, pharmacokinetics (PK), and toxicology

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.